Spinifex Pharmaceuticals is a clinical-stage Australian biotechnology company specialising in the development of products for the treatment of pain.

Pharma Television Interview

Watch the interview of Spinifex Pharmaceuticals CEO, Tom McCarthy, explaining the company's new approach to the treatment of pain with its lead candidate EMA401, Spinifex's business model, and partnering strategies.

Latest News & Events

16TH FEBRUARY 2012  Spinifex Wins a BioSpectrum Editor's Choice Award in the Category of 'BioSpectrum Asia-Pacific Emerging ... More

10TH JANUARY 2012  Spinifex presented at the Biotech Showcase 2012 conference in San Francisco ... More

6TH DECEMBER 2011  Appointment of Spinifex Non-Executive Chairman. ... More

(c)  2012 Spinifex Pharmaceuticals Pty Ltd

Privacy | Disclaimer

Site by: Blue Lily